2020 will go down in history as a year of global health, economic and social crises occurring against the backdrop of increasingly catastrophic climate events. It is a year that defines disruption. However, as we jump into 2021, I’m taking a cue from last season’s development optimists to look for how to convert crisis into opportunity. This year, I will explore with my guests how they see us leveraging disruption for good in a post-COVID world.
R&E Search for Evidence: Highlights from the last quarter of FHI 360’s blog on research and evaluationWritten by
The Research and Evaluation Strategic Initiative team published 14 posts during the last quarter in our blog, R&E Search for Evidence. For those not familiar with our blog, it features FHI 360 thought leaders who write about research and evaluation methodology and practice, compelling evidence for development programming and new findings from recent journal publications. We have published 31 original posts to date.
Now, more than ever, is a time to stand up for science. The U.S. administration’s proposed budget for fiscal year 2018 calls for severe cuts to several key science-generating institutions, including the U.S. National Institutes of Health, the U.S. Centers for Disease Control and Prevention, the U.S. Agency for International Development and the U.S. Environmental Protection Agency. These cuts would result in a deterioration of the science that has allowed the United States to be the global leader in medicine, public health and environmental science. They would also stall progress in global development, an area which has benefited greatly from the many lifesaving solutions produced through science.
Given the administration’s apparent disregard for science, we should take a step back and ask ourselves what may seem like a simple question: What is science and why does it matter? Of the many definitions, the most basic is the standard dictionary definition: a systematically organized body of knowledge on a particular matter. More importantly though, science is a process or way of thinking that seeks to reveal the “truth.” Not knowing the truth about something is like driving through a heavy fog. Science can cut through this fog and reveal the truth.
Girls get the message — from the toys they play with, the TV shows they watch and the attitudes of their parents, teachers and peers — that math is NOT for them! From an early age, girls are taught that math success is about an innate ability that they lack and that being feminine and being good at math are mutually exclusive.
As a result, girls do not develop a positive math identity — an identity that research tells us is key to their interest, participation and persistence in science, technology, engineering and math (STEM) education and careers. Without a solid background in math, girls will not develop the critical STEM skills that will be required for 60 percent of the new jobs that will become available in the 21st century.
There are two pillars of a positive math identity: the belief that you can do math and the belief that you belong. Identity is fluid and dynamic. It is developed through social practice, and it is through social practice that learners develop a sense of who they are. There is no such thing as a “math gene” or a “math brain,” but the myth is perpetuated, and it is particularly harmful to girls and students of color. Teachers and parents often unconsciously convey stereotyped messages that girls do not need to be good in math.
Early symptoms of lung cancer
Lung cancer is increasingly becoming one of the leading killers of not only smokers but, a symptoms of lung cancer large segment of the population in many countries around the world, with alarming incidences in China and India.
Malignant lung tumors have been on the rise 10-15% since the 1900’s. In the 1950’s a British Doctors Study was published that provided strong evidence that there was a link between lung cancer and smoking. Studies that documented the early symptoms of lung cancer in 1964, prompted the U.S. Surgeon General to recommend that people actually stop smoking.
While it is true that other causes have been linked to lung cancer, such as exposure to radon gas, first acknowledged in miners in the 1870’s, asbestos and certain viruses, cigarette smoking has been determined to be the leading cause. There are some 60 known carcinogens in cigarette smoke. Over 91% of lung cancer deaths around the world have been attributed to smoking. The lifetime risk of cancer developing in male smokers is 17%. Women that engage in hormone therapy and that smoke are at even higher risk of developing early symptoms of lung cancer.
When a person stops smoking their chances of lung cancer drastically symptoms of lung cancer in women begin to lower, the body is able to repair some of the lung damage and repair itself. One of the problems for non-smokers is that of passive smoking, which is described as inhalation of smoke from someone who is smoking. Studies conducted in the U.K, Europe and the United States consistently show that there is a relative risk to those exposed., with rates as high as 10-15% being reported in patients that have never smoked. Some research suggests that indirect smoke inhaled is often more dangerous then the smoke inhaled through the cigarette itself.
Some of the early symptoms of lung cancer may include bone pain, fever, and weight loss; more common symptoms are wheezing, hoarse voice, coughing up blood, shortness of breath and chronic coughing. Tumors are common as well, often malignant and can easily lead to metastasis to include cancer of the brain, bone, liver, kidneys, and nearly all areas of the body. There are a small percentage of people who do not suffer any noticeable early symptoms of lung cancer; approximately 10% diagnosed have their cancer detected coincidently through a routine chest x-ray.
The use of CT imaging provides the most through examination and extent of the disease,
Abnormal findings warrant biopsy or bronchoscopy symptoms of lung cancer in men to determine the stage of the lung cancer. The histological type determines the stage of the cancer itself and any treatment alternatives. It is recommended that periodic checkups with your physician or physician’s assistant be mandated to minimize and treat early symptoms of lung cancer before it can spread or become fatal.